PharmaCyte Biotech, Inc. (PMCB) income statement
PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
$0.34+0.00 (+0.53%)
Close on Oct 19, 2026Market cap $48.95MP/E –Yield –
PharmaCyte Biotech, Inc. financial ratios
See a number that looks wrong?